Virtua Healthcare System Joins ITUS Early Cancer Detection Biomarker Study

LOS ANGELES, CA -- (Marketwired) -- 07/05/16 -- ITUS Corporation (NASDAQ: ITUS) today announced that it has enrolled Virtua Healthcare System, part of the Penn Medicine Virtua Cancer Program in Southern New Jersey, to be a part of its ongoing cancer biomarker study.

"The patient blood samples provided by Virtua will assist us in achieving the critical mass we are looking for across several types of solid tumors," said Dr. Amit Kumar, ITUS's Vice Chairman. "We recently visited with the oncology team at Virtua's state-of-the-art facilities, and we are looking forward to collaborating with Virtua on our cancer study."

The Penn Medicine Virtua Cancer Program is accredited by both the American College of Surgeons Commission on Cancer and by the National Accreditation Program for Breast Centers. The Penn Medicine Virtua Cancer Program provides a full range of clinical oncology social work services to meet the psychological needs of cancer patients and their families.

ITUS Corporation

ITUS funds, develops, acquires, and licenses emerging technologies in areas such as Biotechnology. The Company's is developing Cchek™ a platform for non-invasive, cancer screening blood tests. Additional information is available at www.ITUScorp.com.

Forward-Looking Statements: Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect ITUS Corporation's current expectations concerning future events and results. We generally use the words "believes," "expects," "intends," "plans," "anticipates," "likely," "will" and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, those factors set forth in "Item 1A - Risk Factors" and other sections of our Annual Report on Form 10-K for the fiscal year ended October 31, 2015 as well as in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this press release.

Contact:
Dean Krouch
310-484-5184
dkrouch@ITUScorp.com
ITUS Corporation: FOCUSED ON INNOVATION™

Source: ITUS Corporation

Released July 5, 2016